Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharmakia ApS
APS
Active
CVR 44372398
Arnegårds Alle 6
Engineering activities and related technical consultancy · NACE 7112
Est. 2023
2 employees
www.pharmakia.dk
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 2,5M
-30% vs 2024
EBITDA margin
37.0%
-60% vs 2024
Equity ratio
74.5%
Financial strength
Net profit 2025
DKK 734K
-59% vs 2024
EBITDA — year on year
DKK millions
3M
2M
1M
1M
0M
2M
2024
1M
-50%
2025
Key figures
Annual report 2025
Revenue
DKK 2,5M
-30%
EBITDA
DKK 921K
-60%
Net profit
DKK 734K
-59%
Total assets
DKK 1,9M
-29%
Equity
DKK 1,4M
-25%
Employees
2
—
Company information
Legal name
Pharmakia ApS
CVR number
44372398
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
16. oktober 2023
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Arnegårds Alle 6
Phone
+4560588020
Email
sl@pharmakia.dk
Website
www.pharmakia.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engineering activities and related technical consultancy
Companies in Rudersdal
All Denmark companies
Revenue
DKK millions
0M
1M
2M
3M
5M
4M
2024
2M
2025
EBITDA
DKK millions
0M
1M
1M
2M
2M
2M
2024
1M
2025
Income statement
DKK thousands
Item
2024
2025
Revenue
3.560
2.489
Staff expenses
-1.251
-1.569
EBITDA
2.309
921
Depreciation & amort.
-0
-0
EBIT
2.309
921
Net financials
26
23
Profit before tax
2.336
944
Tax
524
210
Net profit
1.812
734
Balance sheet
DKK thousands
Item
2024
2025
Total assets
2.624
1.862
Equity
1.852
1.387
Long-term debt
0
0
Short-term debt
772
475
Total debt
772
475
Financial ratios
5-year trend
EBITDA margin
37.0%
This company
15.8%
Market median
+134% vs market
2024
2025
Equity ratio
74.5%
This company
38.2%
Market median
+95% vs market
2024
2025
Return on equity
53.0%
This company
18.4%
Market median
+188% vs market
2024
2025
Net profit margin
29.5%
This company
8.1%
Market median
+264% vs market
2024
2025
Asset turnover
1.34×
This company
1.12×
Market median
+20% vs market
2024
2025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-16 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SL
Stephane Laurent Thomas Labrosse
Management
Management
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Pharmakia Holding ApS
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Pharmakia Holding ApS
Pharmakia ApS
(this company)
Board network connections
Board members of Pharmakia ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Stephane Laurent Thomas Labrosse
Management
0 companies